Deflazacort Oral Suspension
Product Images NDC 27808-249

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Deflazacort Oral Suspension (NDC 27808-249). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cranbury Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tris Chemdraw Structure (Deflazacort Oral Suspension 1)

Chemical structure diagram of deflazacort showing its steroid backbone with attached functional groups, including hydroxyl, ketone, and ester moieties.*

FDA Label Image

Figurei (Deflazacort Oral Suspension 10)

An instructional illustration depicting a hand using a dropper to transfer liquid from a cup, with a spoon positioned next to the cup. This diagram likely demonstrates how to administer or mix an oral suspension dose.*

FDA Label Image

Figurej (Deflazacort Oral Suspension 11)

An instructional illustration showing a hand stirring a spoon inside a cup filled with liquid, with an arrow indicating a stirring motion.*

FDA Label Image

Figurek (Deflazacort Oral Suspension 12)

An illustration showing a hand opening a bottle by lifting the cap upwards, indicating how to open the bottle of Deflazacort Oral Suspension.*

FDA Label Image

Figurel (Deflazacort Oral Suspension 13)

An instructional diagram showing a hand holding a syringe with labeled parts 'Plunger' and 'Barrel.' An upward arrow indicates the plunger should be pulled up, suggesting a step in syringe use or preparation.*

FDA Label Image

Label (Deflazacort Oral Suspension 14)

Label for Deflazacort Oral Suspension 22.75 mg/mL by Cranbury Pharmaceuticals, LLC. The oral suspension comes in a 13 mL bottle. The label includes storage instructions, manufacturer information (Tris Pharma, Inc.), and indicates the product is for oral administration only with prescription use.*

FDA Label Image

Figurea (Deflazacort Oral Suspension 2)

Illustration showing components of Deflazacort Oral Suspension packaging, including the oral suspension bottle, carton, bottle adapter, oral dispenser, and a household cup with spoon for administration.*

FDA Label Image

Figureb (Deflazacort Oral Suspension 3)

An instructional illustration showing a hand holding a bottle with motion lines indicating shaking, accompanied by the text 'Shake Well'. This image depicts the proper handling of an oral suspension medication bottle before use.*

FDA Label Image

Figurec (Deflazacort Oral Suspension 4)

An instructional illustration showing a hand pressing down on the top of a vial's rubber stopper. Two arrows indicate the direction of pressure applied to open or puncture the vial seal, demonstrating how to properly access the vial contents.*

FDA Label Image

Figured (Deflazacort Oral Suspension 5)

An instructional diagram showing hands pressing down on a bottle adapter using both thumbs. The image highlights the 'ribbed end' of the adapter, illustrating the correct method to open or activate the bottle cap mechanism.*

FDA Label Image

Figuree (Deflazacort Oral Suspension 6)

An instructional illustration showing a dosing syringe labeled with measurement markings along the barrel. The plunger is highlighted, indicating its position inside the barrel, used for measuring and administering oral suspension medication doses.*

FDA Label Image

Figuref (Deflazacort Oral Suspension 7)

An instructional illustration showing a hand holding a syringe-like dosing device with the plunger labeled. The device is being inserted into a bottle, with a large downward arrow indicating the plunger should be pushed down to withdraw or dispense the suspension.*

FDA Label Image

Figureg (Deflazacort Oral Suspension 8)

An instructional illustration depicting the proper technique for measuring a dose from an oral medication syringe. It highlights that the dose should be measured from the widest part of the syringe plunger.*

FDA Label Image

Figureh (Deflazacort Oral Suspension 9)

An illustration showing a hand pulling a dosing syringe upward from an oral suspension bottle, with an arrow indicating upward movement and a twisting motion to remove the syringe from the bottle opening.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.